CAFC-PTOAugust 27, 2026·25-2099·Dismissed; order issued as the mandate on August 27, 2026.
Aerin Medical Inc. v. Neurent Medical Inc.
Patent Trial and Appeal Board
Holding
The Federal Circuit dismissed the appeals under Federal Rule of Appellate Procedure 42(b) by party agreement. Each side will bear its own costs.
Why It Matters
The order ends these PTAB appeals without any Federal Circuit merits ruling on the underlying IPR issues.
Full Summary
Aerin Medical Inc. v. Neurent Medical Inc. [Order]
The Federal Circuit dismissed the appeals under Federal Rule of Appellate Procedure 42(b) by party agreement. Each side will bear its own costs.
The order ends these PTAB appeals without any Federal Circuit merits ruling on the underlying IPR issues.
Dismissed; order issued as the mandate on August 27, 2026.
The appeals arose from six PTAB IPR proceedings involving Aerin Medical, The Foundry, and Neurent entities.
The Federal Circuit did not address patentability, claim construction, or any other merits issue.
Dismissal was entered under FRAP 42(b) based on the parties' agreement.
The court ordered each side to bear its own costs and issued the order as the mandate the same day.
non-precedential waiver / forfeiture claim construction
non-precedential waiver / forfeiture claim construction
non-precedential waiver / forfeiture
Key Points
- The appeals arose from six PTAB IPR proceedings involving Aerin Medical, The Foundry, and Neurent entities.
- The Federal Circuit did not address patentability, claim construction, or any other merits issue.
- Dismissal was entered under FRAP 42(b) based on the parties' agreement.
- The court ordered each side to bear its own costs and issued the order as the mandate the same day.
- Fed. Cir. · Oct. 6, 2026Inari Agriculture, Inc. v. Corteva Agriscience LLC
- Fed. Cir. · Oct. 5, 2026O'Reilly Winship LLC v. SnapRays LLC
- Fed. Cir. · Oct. 1, 2026Satius Holding, LLC v. Samsung Electronics Co., Ltd.
- Fed. Cir. · Sept. 30, 2026WSOU Investments LLC v. Salesforce, Inc.
- Fed. Cir. · Sept. 30, 2026TEVA PHARMACEUTICALS INTERNATIONAL GMBH v. ELI LILLY AND COMPANY